END STAGE RENAL DISEASE

This adverse event was reported 18257 times

These drugs are most commonly taken by patients reporting END STAGE RENAL DISEASE:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 10576
1 ESOMEPRAZOLE MAGNESIUM 10301
2 LANSOPRAZOLE 9804
3 PANTOPRAZOLE SODIUM 7567
4 DEXLANSOPRAZOLE 4888
5 OMEPRAZOLE 3707
6 FUROSEMIDE 3384
7 PANTOPRAZOLE 2907
8 LISINOPRIL 2831
9 ASPIRIN 2563
See all common drugs associated with END STAGE RENAL DISEASE

END STAGE RENAL DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMMONIUM CHLORIDE 68 0.2720
1 OMEPRAOLE, SODIUM BICARBONATE 63 0.1975
2 FAMOTITINE 576 0.1956
3 BUFFERED ASPIRIN 256 0.1823
4 DEXLANSOPRAZOLE 4888 0.1171
5 BISMUTH SUBSALICYLATE 472 0.0847
6 CIMETIDINE HYDROCHLORIDE 13 0.0813
7 CLINDAMYCIN PHOSPHATE 448 0.0812
8 OMEPRAZOLE, SODIUM BICARBONATE 77 0.0807
9 CALCIUM ACETATE 437 0.0804
See all drugs enriched for association with END STAGE RENAL DISEASE

END STAGE RENAL DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bismuth [EPC] 472 0.0847
1 Polyene Antimicrobial [EPC] 25 0.0610
2 Vitamin D3 Analog [EPC] 736 0.0363
3 Vitamin D2 Analog [EPC] 184 0.0258
4 alpha-Hydroxy Acid [EPC] 55 0.0252
5 Non-narcotic Antitussive [EPC] 372 0.0221
6 Central alpha-2 Adrenergic Agonist [EPC] 1124 0.0208
7 Cephalosporin Antibacterial [EPC] 169 0.0197
8 Antihypoglycemic Agent [EPC] 82 0.0191
9 Proton Pump Inhibitor [EPC] 10943 0.0187
See all drug classes enriched for association with END STAGE RENAL DISEASE